Hematology/Oncology Lenox Hill Hospital — New York, New York

Hematology/Oncology Lenox Hill Hospital is a clinical research site located in New York, New York, United States 10075.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Hematology/Oncology Lenox Hill Hospital has participated in 1 clinical trials.

Therapeutic areas: Platinum Sensitive Ovarian Cancer, Ovarian Cancer.

Sponsors: Marker Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hematology/Oncology Lenox Hill Hospital?

Hematology/Oncology Lenox Hill Hospital has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hematology/Oncology Lenox Hill Hospital conducted?

Hematology/Oncology Lenox Hill Hospital has 1 clinical trials on record. Their work covers Platinum Sensitive Ovarian Cancer, Ovarian Cancer.

Is Hematology/Oncology Lenox Hill Hospital accredited by Crixeo Health?

Hematology/Oncology Lenox Hill Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hematology/Oncology Lenox Hill Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.